Eicos Sciences News Today

Eicos Sciences’ Aurlumyn is the first FDA-approved treatment for the prevention of amputation caused by severe frostbite.

The Food and Drug Administration this month approved the first ever medication to treat severe frostbite in adults, a move that could reduce the risk...

Frostbite may have met its match. The U.S. Food and Drug Administration (FDA) has approved the first medication to treat severe frostbite, the agency announced this week. The drug, iloprost (brand name Aurlumyn) is intended to reduce the risk of finger and toe amputations due to dangerously cold extremities. NEED A 'WINTER RESET'? EXPERTS SHARE

WASHINGTON, DC, February 15, 2024 (ENS) - The U.S. Food and Drug Administration has approved a new drug - an injection to treat severe frostbite in adults that reduces the risk of finger or toe, nose or ear amputation. The iloprost injection, marketed under the brand name Aurlumyn, is a vasodilator, a drug that opens blood vessels and prevents blood clotting. %environment_news_service% news environment latest on forests, oceans, climate, wildlife, fisheries, transportation, business

The U.S. Food and Drug Administration (FDA) approved the first medication to treat severe frostbite, the agency announced this week. Dr. Marc Siegel, Fox News medical contributor, weighed in.

The U.S. Food and Drug Administration (FDA) has approved the first medication to treat severe frostbite, the agency announced this week. Dr. Marc Siegel weighs in.

Great news for Minnesota lives and limbs this snowy week. The U.S. Food and Drug Administration just approved a treatment – the very first — for severe frostbite. The drug, iloprost, could save the fingers and toes of adults at risk of amputation. Every year, the Minnesota Department of Health tracks the health toll of extreme cold. Frostbite sends hundreds of Minnesotans to the hospital each ...

Severe frostbite, when both the skin and underlying tissue are frozen and blood flow stops, sometimes requires amputation

The FDA approved an injection to treat severe frostbite in adults to reduce the risk of finger or toe amputation.

Credit: Michigan medicine Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate. Researchers at Michigan Medicine found that an internet application improved their ability to spot pulmonary arterial hypertension in patients with systemic sclerosis, or scleroderma. The unpredictable condition is marked by tightening of the skin that can damage internal organs. The algorithm, aptly named DET...